Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15012589 | 0.79 | CYP2C9 (0.40) | CYP2C9ATMMAOAMAOBHDAC3 | |
| SCHEMBL5668650 | 0.76 | CYP2C9 (0.44) | CYP2C9ATMMAOAMAOBHDAC3 | |
| SCHEMBL16910595 | 0.76 | CYP2C9 (0.37) | CYP2C9ATMMAOAMAOBNISCH | |
| SCHEMBL11647868 | 0.75 | CYP2C9 (0.36) | CYP2C9ATMNISCHMEN1KMT2A | |
| SCHEMBL16162235 | 0.72 | BRD4 (0.33) | MEN1KMT2AALDH1A1KDM4ETP53 | |
| SCHEMBL9839675 | 0.69 | — | — | |
| SCHEMBL5532233 | 0.67 | MAOA (0.42) | CYP2C9ATMMAOAMAOBHDAC3 | |
| SCHEMBL7101024 | 0.67 | TDP1 (0.32) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL25998053 | 0.65 | MAOA (0.33) | CYP2C9MAOAMAOBKCNA3 | |
| SCHEMBL30421439 | 0.64 | MAOA (0.40) | CYP2C9ATMMAOAMAOBHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 655 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111596397-B | Polarizing film and display device using the same | 三星显示有限公司 | 2025-02-25 | — | — | CN | claimed |
| US-11459425-B2 | Composition for preparing hybrid resin, hybrid resin and hybrid resin film prepared therefrom | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-10-04 | — | — | US | claimed |
| US-11028251-B2 | Resin composition, film, infrared cut filter, method of manufacturing infrared cut filter, solid image pickup element, infrared sensor, and camera module | FUJIFILM CORPORATION (JP) | 2021-06-08 | — | — | US | claimed |
| CN-107614626-B | Colored composition, film, color filter, pattern forming method, method for manufacturing color filter, solid imaging element, and infrared sensor | 富士胶片株式会社 | 2020-12-25 | — | — | CN | claimed |
| CN-111393278-B | Usnea longissima derivative and application thereof in preparation of medicine for treating gallbladder cancer | 山西白求恩医院(山西医学科学院) | 2020-11-20 | — | — | CN | claimed |
| EP-2090352-B1 | Device for reducing dibenzo-dioxin and dibenzo-furan emissions from catalytic converters containing transition metals | MAN TRUCK & BUS SE (DE) | 2020-09-09 | — | — | EP | claimed |
| CN-111393278-A | Usnea longissima derivative and application thereof in preparation of medicine for treating gallbladder cancer | 山西白求恩医院(山西医学科学院) | 2020-07-10 | — | — | CN | claimed |
| US-20180118865-A1 | NEAR INFRARED ABSORBING COLORANT POLYMER, COMPOSITION, FILM, OPTICAL FILTER, PATTERN FORMING METHOD, AND DEVICE | FUJIFILM CORPORATION (JP) | 2018-05-03 | — | — | US | claimed |
| EP-2615179-B1 | NOVEL BIOLOGICAL DETECTION METHOD FOR DIOXINS IN SERUM, AND A DIAGNOSTIC USE THEREFOR IN METABOLIC SYNDROME AND RELATED CONDITIONS | UNIV-INDUSTRY COOP GROUP OF KYUNG HEE UNIV (KR) | 2017-08-02 | — | — | EP | claimed |
| US-20160040061-A1 | FLEXIBLE POLYMERIC MATERIALS CONTAINING TRIBOLUMINESCENT COMPOUNDS, PROTECTIVE DEVICES CONTAINING SUCH MATERIALS, AND METHODS OF MANUFACTURING THE SAME | FULLPROOF LLC (US) | 2016-02-11 | — | — | US | claimed |
| US-7252785-B2 | Composition of a radiation-absorbing tert-alkylphenoxy-substituted polycyclic ccmpound and a curable IR-reflecting component of achiral nematic polymerizable monomer, a chiral polymerizable monomer, a cholesteric polymerizable monomer, and a cholesteric polymer in a polymerizable diluent | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-07 | — | — | US | claimed |
| US-20050221091-A1 | Composition for producing a thermal insulation coating | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-06 | — | — | US | claimed |
| EP-1373272-B1 | TERT. ALKYLPHENOXY SUBSTITUTED POLYCYCLIC COMPOUNDS | BASF AG (DE) | 2005-06-29 | — | — | EP | claimed |
| EP-1521815-A2 | COMPOSITION FOR PRODUCING A THERMAL INSULATION COATING | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-13 | — | — | EP | claimed |
| US-20040049030-A1 | Tert alkylphenoxy substituted polycyclic compounds | BASF SE (DE) | 2004-03-11 | — | — | US | claimed |
| WO-2004005427-A2 | COMPOSITION FOR PRODUCING A THERMAL INSULATION COATING | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-15 | — | — | WO | claimed |
| EP-1373272-A2 | TERT. ALKYLPHENOXY SUBSTITUTED POLYCYCLIC COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-02 | — | — | EP | claimed |
| WO-2002076988-A2 | TERT. ALKYLPHENOXY SUBSTITUTED POLYCYCLIC COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-03 | — | — | WO | claimed |
| EP-0548772-B1 | Toner for the development of electrostatic images | MITSUBISHI CHEM CORP (JP) | 1996-04-10 | — | — | EP | claimed |
| EP-0057362-B1 | DIBENZOFURANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BASF Aktiengesellschaft (DE) | 1984-06-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040049030-A1 | Tert alkylphenoxy substituted polycyclic compounds | NR3C1, NR1H4, NR5A1 | CYP2C9 677/4885ATM 3195/4885MAOA 2529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.